📰 Study Evaluating News
Page 2 - Study Evaluating News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Evaluating. Real-time updates on events, politics, business and more.
December 8, 2023
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to...
July 19, 2023
Enrollment Complete in Study Evaluating the Performance of the Ringer™ Perfusion Balloon Catheter in Patients Undergoing Percutaneous Coronary InterventionsWAYNE, Pa., July 19, 2023 -- Teleflex...
June 29, 2023
Find the facts of Portal Hypertension and TIPS including Causes, Symptoms, Diagnosis & Treatment and more information.
June 20, 2023
20.06.2023 - GOTHENBURG, SE / ACCESSWIRE / June 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, June 20, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinsons ...
June 20, 2023
IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs ...
May 31, 2023
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment... | May 31, 2023
May 31, 2023
/PRNewswire/ -- The American Society of Clinical Oncology (ASCO) recently announced the selected abstracts for the prestigious ASCO 2023 Annual Meeting. Four...
May 9, 2023
Axsome Therapeutics reported a 13% year-over-year increase in prescriptions for Sunosi for adults with excessive daytime sleepiness.
March 17, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was...
February 28, 2023
During its fourth-quarter and full-year 2022 earnings call, Axsome Therapeutics provided business updates on Sunosi and AXS-12.